Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...
Zacks.com on MSN2h
Is Trending Stock CVS Health Corporation (CVS) a Buy Now?CVS Health (CVS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...
J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers ...
A number of analysts have downgraded estimates for CVS Health CVS following the pharmacy benefit and retail pharmacy ...
CVS Health on Wednesday named Steve Nelson, a former UnitedHealth insurance head, to run its Aetna business, where rising ...
CVS also reported its quarterly results today, with revenue exceeding but earnings missing the street estimates.
CVS Health fell short on third-quarter profit, but it posted strong sales and shook up leadership under new CEO David Joyner ...
6d
CVS Health Corp (CVS) reports robust growth in retail pharmacy and health services, while navigating challenges in its health ...
Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback